Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ZFYVE26 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-ZFYVE26 a été validé pour WB et EIA. Il convient pour détecter ZFYVE26 dans des échantillons de Humain, Souris et Rat.
N° du produit ABIN783824

Aperçu rapide pour ZFYVE26 anticorps (C-Term) (ABIN783824)

Antigène

Voir toutes ZFYVE26 Anticorps
ZFYVE26 (Zinc Finger, FYVE Domain Containing 26 (ZFYVE26))

Reactivité

  • 10
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 10
Lapin

Clonalité

  • 10
Polyclonal

Conjugué

  • 6
  • 2
  • 1
  • 1
Cet anticorp ZFYVE26 est non-conjugé

Application

  • 6
  • 4
  • 2
  • 2
  • 2
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Épitope

    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term

    Specificité

    This antibody reacts to ZFYVE26.

    Purification

    Affinity chromatography

    Immunogène

    16 amino acid peptide near the carboxy terminus of human SPG15.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1,0 mg/mL

    Buffer

    PBS containing 0.02 % sodium azide as preservative

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store the antibody undiluted at 2-8 °C.
  • Antigène

    ZFYVE26 (Zinc Finger, FYVE Domain Containing 26 (ZFYVE26))

    Autre désignation

    ZFYVE26

    Sujet

    Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders. Spastic paraplegia with thinning of the corpus callosum (ARHSP-TCC) is a relatively frequent form of complicated hereditary spastic paraplegia in which mental retardation and muscle stiffness at onset are followed by slowly progressive paraparesis and cognitive deterioration. SPG15 is the second gene known to be responsible for ARHSP-TCC in the Italian population. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. SPG15 encodes a protein containing a FYVE zinc finger binding domain which is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. SPG15 mRNA is widely distributed in human tissues, as well as in rat embryos, suggesting a possible role for this protein during embryonic development. SPG15 co-localizes partially with endoplasmic reticulum and endosome markers, suggesting a role in intracellular trafficking. Multiple isoforms of SPG15 are known to exist.Synonyms: KIAA0321, Zinc finger FYVE domain-containing protein 26

    ID gène

    23503

    NCBI Accession

    NP_056161

    UniProt

    Q68DK2
Vous êtes ici:
Chat with us!